tiprankstipranks
pc:amphi

Amphix Bio

Amphix Bio is a biotechnology company developing a new class of peptide therapeutics for neurological injuries, neurodegenerative diseases, and musculoskeletal disorders. The company’s Supramolecular Therapeutic Peptide (STP) platform assembles nanostructures that activate cell receptors and combines peptide modifications with a proprietary sequence library to optimize therapeutic properties.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$13M
Total Amount Raised$13M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$13M
Latest Funding Amount$13M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 18, 2025
Seed Round
$12.50M

Related News and Analysis